Literature DB >> 9745454

Salt-wasting congenital adrenal hyperplasia: detection of mutations in CYP21B gene in a Chilean population.

C E Fardella1, H Poggi, P Pineda, J Soto, I Torrealba, A Cattani, E Oestreicher, A Foradori.   

Abstract

The steroid 21-hydroxylase deficiency (21OHD) is the most frequent cause of congenital adrenal hyperplasia. We have characterized the disease-causing mutations in the 21-hydroxylase genes of 63 patients with salt-wasting congenital adrenal hyperplasia from a Chilean population of Hispanic origin, a group that has been scarcely evaluated. Using allele-specific PCR, lesions were identified in 97 chromosomes out of 126 tested (77%). The most frequent findings were the gene deletion or large gene conversion (LGC) = 22.9%, I2 splice = 19%, R357W = 12.7%, and Q319X = 10.5%. We did not find alleles with the mutation F308insT and we found three alleles with the cluster E6. The frequency of the point mutation R357W was at least two times more frequent than the one found in Caucasians populations, but similar to that communicated in Asian populations; this finding may be explained by the Asian ancestry of our South-Amerindian population. The frequency of Q319X was also high, similar only to those patients studied in Italy and in a neighboring Argentinian population. In summary, this is a genetic characterization of 21OHD made in an almost pure Hispanic population in Latin America. The high frequency of deletion of CYP21B gene, I2 splice, R357W, and Q319X mutations probably reflects the European-Caucasian-Spanish influence of the conquerors, mixed with Amerindians of Asian ancestry and modulated by other European immigrations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745454     DOI: 10.1210/jcem.83.9.5071

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Mutations in the CYP21 B gene in a Chilean population with simple virilizing congenital adrenal hyperplasia.

Authors:  C E Fardella; H Poggi; J Soto; I Torrealba; A Cattani; F Ugarte; A Cortinez; A Foradori
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

2.  Detection of a novel severe mutation affecting the CYP21A2 gene in a Chilean male with salt wasting congenital adrenal hyperplasia.

Authors:  Eugenio Arteaga; Felipe Valenzuela; Carlos F Lagos; Marcela Lagos; Alejandra Martinez; Rene Baudrand; Cristian Carvajal; Carlos E Fardella
Journal:  Endocrine       Date:  2019-09-30       Impact factor: 3.633

3.  Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.

Authors:  Mayara Jorgens Prado; Simone Martins de Castro; Cristiane Kopacek; Maricilda Palandi de Mello; Thaiane Rispoli; Tarciana Grandi; Cláudia Maria Dornelles da Silva; Maria Lucia Rosa Rossetti
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 4.  21-Hydroxylase deficiency: from molecular genetics to clinical presentation.

Authors:  E Trakakis; D Laggas; E Salamalekis; G Creatsas
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

5.  A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily.

Authors:  M Niceta; M Bono; C Fabiano; F Pojero; F Niceta; P Sammarco; G Corsello; P Garofalo
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.